Login
$ARQT
$31.68 -$0.13 (0.41%) Close

$ARQT 8-K/A SEC Filings

Filed On Filing
07 Sep 2023 8-K/A: Departure/Election of Directors or Officers; Compensation

Smither CIC Agreement ARCUTIS BIOTHERAPEUTICS, INC. SEVERANCE AND CHANGE IN CONTROL AGREEMENT This Severance and Change in Control Agreement (the “Agreement”), is entered into by and between John Smither (the “Executive”) and Arcutis Bio...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support